Trevena, Inc. (NASDAQ:TRVN) is set to post its quarterly earnings results before the market opens on Wednesday, November 1st. Analysts expect Trevena to post earnings of ($0.33) per share for the quarter.

Trevena (NASDAQ:TRVN) last issued its earnings results on Thursday, August 3rd. The biopharmaceutical company reported ($0.35) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.35). On average, analysts expect Trevena to post $-1.27 EPS for the current fiscal year and $-0.76 EPS for the next fiscal year.

Shares of Trevena, Inc. (NASDAQ:TRVN) opened at 1.45 on Tuesday. The company’s 50-day moving average price is $2.25 and its 200 day moving average price is $2.58. The company’s market cap is $86.56 million. Trevena, Inc. has a 52 week low of $1.43 and a 52 week high of $8.00.

A number of analysts have recently commented on the company. Cowen and Company restated a “buy” rating and issued a $10.00 target price on shares of Trevena in a research note on Friday, August 4th. Oppenheimer Holdings, Inc. set a $5.00 price target on Trevena and gave the stock a “buy” rating in a report on Thursday, October 12th. HC Wainwright reduced their price target on Trevena from $8.00 to $7.00 and set a “buy” rating for the company in a report on Thursday, October 12th. Barclays PLC cut Trevena from an “overweight” rating to an “equal weight” rating and reduced their price target for the stock from $15.00 to $2.50 in a report on Monday, October 16th. Finally, Zacks Investment Research cut Trevena from a “hold” rating to a “sell” rating in a report on Wednesday, July 26th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and eleven have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $9.25.

COPYRIGHT VIOLATION WARNING: “Trevena, Inc. (TRVN) Set to Announce Earnings on Wednesday” was posted by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at

An institutional investor recently raised its position in Trevena stock. California State Teachers Retirement System raised its position in shares of Trevena, Inc. (NASDAQ:TRVN) by 0.5% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 97,107 shares of the biopharmaceutical company’s stock after acquiring an additional 500 shares during the quarter. California State Teachers Retirement System owned approximately 0.16% of Trevena worth $223,000 as of its most recent SEC filing. 60.19% of the stock is owned by hedge funds and other institutional investors.

About Trevena

Trevena Inc is a biopharmaceutical company, which is engaged in developing various therapies. The Company is developing OLINVO, a u-receptor G protein pathway selective modulator (u-GPS) for the management of moderate-to-severe acute pain where intravenous (IV) administration is preferred. It is focused on commercializing it in the United States for use in acute care settings, such as hospitals and ambulatory surgery centers.

Earnings History for Trevena (NASDAQ:TRVN)

Receive News & Ratings for Trevena Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trevena Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.